David M. Epstein

Insider Reports History

Location: Osi Pharmaceuticals, Inc., 41 Pinelawn Road, Melville, NY
Signature: /s/ Ruoyu Chen, as attorney-in-fact for David M. Epstein
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David M. Epstein:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Black Diamond Therapeutics, Inc.	Officer Title: President and Chief Executive Officer, Director	Common Stock	671K	$1.83M	$2.73	Jun 27, 2023	Direct
Black Diamond Therapeutics, Inc.	Officer Title: President and Chief Executive Officer, Director	Common Stock	16.6K	$45.3K	$2.73	Jun 27, 2023	Indirect
GYRE THERAPEUTICS, INC.	Director	Stock Option (Right to Buy)	26K			Jun 4, 2025	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by David M. Epstein

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
GYRE	GYRE THERAPEUTICS, INC.	Jun 4, 2025	1	$0	4	Jun 6, 2025	Director
GYRE	GYRE THERAPEUTICS, INC.	Aug 14, 2024	1	$0	4	Aug 16, 2024	Director
GYRE	GYRE THERAPEUTICS, INC.	Aug 6, 2024	1	$0	4	Aug 8, 2024	Director
GYRE	GYRE THERAPEUTICS, INC.	Aug 6, 2024	0	$0	3	Aug 8, 2024	Director
BDTX	Black Diamond Therapeutics, Inc.	Jun 27, 2023	1	-$168K	4	Jun 28, 2023	Officer Title: President and Chief Executive Officer, Director
BDTX	Black Diamond Therapeutics, Inc.	Feb 13, 2023	1	$0	4	Feb 15, 2023	Officer Title: President and Chief Executive Officer, Director
BDTX	Black Diamond Therapeutics, Inc.	Feb 15, 2022	1	$0	4	Feb 17, 2022	Officer Title: President and Chief Executive Officer, Director